CNS Metastases in Patients With MET Exon 14–Altered Lung Cancers and Outcomes With Crizotinib

PURPOSE: Although MET exon 14 (METex14)–altered lung cancers were first identified more than a decade and a half ago, the frequency of CNS metastatic disease remains poorly defined. Furthermore, the seminal trial of crizotinib in these patients (PROFILE 1001) did not report patterns of CNS response...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCO Precis Oncol
Main Authors: Offin, Michael, Luo, Jia, Guo, Robin, Lyo, John K., Falcon, Christina, Dienstag, Jordan, Wilkins, Olivia, Chang, Jason, Rudin, Charles M., Riely, Gregory, Rekhtman, Natasha, Arcila, Maria E., Heller, Glenn, Ladanyi, Marc, Li, Bob T., Kris, Mark G., Paik, Paul, Drilon, Alexander
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2020
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446485/
https://ncbi.nlm.nih.gov/pubmed/32923895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00098
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker